EP1311239A4 - Orale verabreichung von peptiden - Google Patents

Orale verabreichung von peptiden

Info

Publication number
EP1311239A4
EP1311239A4 EP00952034A EP00952034A EP1311239A4 EP 1311239 A4 EP1311239 A4 EP 1311239A4 EP 00952034 A EP00952034 A EP 00952034A EP 00952034 A EP00952034 A EP 00952034A EP 1311239 A4 EP1311239 A4 EP 1311239A4
Authority
EP
European Patent Office
Prior art keywords
peptides
oral administration
oral
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00952034A
Other languages
English (en)
French (fr)
Other versions
EP1311239A1 (de
Inventor
Hack-Joo Kim
Heung-Man An
Min-Jong Cha
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hyundai Pharm Co Ltd
Original Assignee
Hyundai Pharmaceutical Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hyundai Pharmaceutical Ind Co Ltd filed Critical Hyundai Pharmaceutical Ind Co Ltd
Publication of EP1311239A1 publication Critical patent/EP1311239A1/de
Publication of EP1311239A4 publication Critical patent/EP1311239A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
EP00952034A 2000-08-11 2000-08-11 Orale verabreichung von peptiden Withdrawn EP1311239A4 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/KR2000/000892 WO2002013782A1 (en) 2000-08-11 2000-08-11 Oral delivery of peptide

Publications (2)

Publication Number Publication Date
EP1311239A1 EP1311239A1 (de) 2003-05-21
EP1311239A4 true EP1311239A4 (de) 2005-06-22

Family

ID=19198254

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00952034A Withdrawn EP1311239A4 (de) 2000-08-11 2000-08-11 Orale verabreichung von peptiden

Country Status (6)

Country Link
EP (1) EP1311239A4 (de)
JP (1) JP2004506003A (de)
CN (1) CN1479609A (de)
AU (1) AU2000264796A1 (de)
CA (1) CA2420032A1 (de)
WO (1) WO2002013782A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6761901B1 (en) 2000-05-02 2004-07-13 Enzrel Inc. Liposome drug delivery
US8658202B2 (en) 2001-04-25 2014-02-25 Western University Of Health Sciences Coated drug delivery formulations
US6759058B1 (en) * 2001-04-25 2004-07-06 Western Center For Drug Development College Of Pharmacy Western University Of Health Sciences Enteric-coated proliposomal formulations for poorly water soluble drugs
AU2003210477A1 (en) 2002-01-09 2003-07-30 Enzrel, Inc. Liposome drug delivery of polycyclic, aromatic, antioxidant or anti-inflammatory compounds
CN100371018C (zh) * 2003-06-12 2008-02-27 刘青松 降钙素组合物
JP4669665B2 (ja) * 2004-04-12 2011-04-13 正彦 阿部 細胞毒性のないポリカチオン修飾リポソームおよびその製造方法
WO2006062506A1 (en) * 2004-12-03 2006-06-15 Enzrel, Inc. Chitosan-coated liposome drug delivery of antioxidant or anti-inflammatory compounds
JP2008179563A (ja) * 2007-01-24 2008-08-07 Cosmo Shokuhin Kk 有用リン脂質組成物を含む機能性素材及び機能性食品
WO2009149537A1 (en) * 2008-06-12 2009-12-17 Christine Allen Injectable polymer-lipid blend
RU2015144851A (ru) 2009-06-18 2019-01-10 Серенити Фармасьютикалз, Элэлси Безопасное применение десмопрессина
CN103127003B (zh) * 2013-03-19 2014-05-07 广东彼迪药业有限公司 一种奥美拉唑肠溶微丸、胶囊及其制备方法
CN105902400B (zh) * 2016-06-17 2019-10-11 四川百奥可生物科技有限责任公司 一种包裹生物酶的微粒及其制备方法和应用
CN107952063A (zh) * 2017-12-27 2018-04-24 北京四环生物制药有限公司 降钙素片及其制备方法
CN114010801B (zh) * 2021-11-16 2023-09-26 上海理工大学 一种l-抗坏血酸棕榈酸酯修饰的小分子肽脂质体及其制备与应用
CN114081963B (zh) * 2021-11-16 2023-09-26 上海理工大学 一种提高活性肽生物利用度的纳米载体及其制备与应用
CN116407621A (zh) * 2021-12-30 2023-07-11 武汉虹辰远荣生物制品有限公司 一种能辅助预防老年痴呆症的纳豆产品

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4615885A (en) * 1983-11-01 1986-10-07 Terumo Kabushiki Kaisha Pharmaceutical composition containing urokinase
EP0855179A2 (de) * 1997-01-16 1998-07-29 Lipotec, S.A. Pharmazeutische Zubereitung umfassend mit einem Überzug versehene Kapseln oder Tabletten enthaltende in einen Wirkstoff enthaltendes Liposomenpulver

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4615885A (en) * 1983-11-01 1986-10-07 Terumo Kabushiki Kaisha Pharmaceutical composition containing urokinase
EP0855179A2 (de) * 1997-01-16 1998-07-29 Lipotec, S.A. Pharmazeutische Zubereitung umfassend mit einem Überzug versehene Kapseln oder Tabletten enthaltende in einen Wirkstoff enthaltendes Liposomenpulver

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO0213782A1 *

Also Published As

Publication number Publication date
CN1479609A (zh) 2004-03-03
CA2420032A1 (en) 2002-02-21
AU2000264796A1 (en) 2002-02-25
JP2004506003A (ja) 2004-02-26
EP1311239A1 (de) 2003-05-21
WO2002013782A1 (en) 2002-02-21

Similar Documents

Publication Publication Date Title
NO20071303L (no) Farmasoytiske preparater
ITTO20010008A0 (it) Formulazione farmaceutica
EE200000395A (et) Peroraalne farmatseutiline pulseeriva vabanemisega annusvorm
DK1210113T3 (da) Kombinerede vaccinepræparater
ATE296619T1 (de) Feste orale dosierungsform von simethicon
NO20033556D0 (no) Farmasöytiske preparater
CY2014003I1 (el) Φαρμακοτεχνικες μορφες εχινοκανδινης που περιεχουν επιφανειοδραστικα που σχηματιζουν μικκυλιο
FIU20000164U0 (fi) Uusi farmaseuttinen formulaatio
DE60024988D1 (de) Herstellung von therapeutischem mikroschaum
IS5245A (is) Lyfjablanda úr ómeprasól
ATE392890T1 (de) Hydrogel-gesteuerte dosierungsform
EE200000383A (et) Peroraalne farmatseutiline pikendatud vabanemisega annusvorm
FI991485A0 (fi) Uusi farmaseuttinen koostumus
EP1383518A4 (de) Orale abgabe von makromolekülen
NO20030627L (no) Hydrogel-drevet medikament doseringsform
NO20020304L (no) Konserverte farmasoytiske preparater
EP1311239A4 (de) Orale verabreichung von peptiden
ATE252915T1 (de) Formulierung zur verzögerten freisetzung von peptiden
EE05020B1 (et) Glburiidi ravimkoostis
DE60126089D1 (de) Verabreichungssystem
DZ3219A1 (fr) Vaccin
NO20015670D0 (no) Forbedrede farmasöytiske formuleringer
NO20025114L (no) Trombopoitein-reseptormodulerende peptid
NO20022606L (no) Farmasöytiske kombinasjoner
ATE298576T1 (de) Arzneizubereitungen

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030211

AK Designated contracting states

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

RBV Designated contracting states (corrected)

Designated state(s): BE DE ES FR GB IT

A4 Supplementary search report drawn up and despatched

Effective date: 20050506

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61K 9/28 B

Ipc: 7A 61K 9/20 B

Ipc: 7A 61K 9/127 A

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20060301